Endeavour Vision has announced the closing of its Heathtech fund Endeavour Medtech Growth II (EMG II) LP at...
Up To Date
Latest News
The Swiss biotech industry experienced a record investment in the pandemic year 2020, according to the new...
A new study on the persistence of neutralising antibodies to SARS-CoV-2 in the blood suggests that humoral...
Swiss BioVersys has received €20mfrom the European Investment Bank to push the development of new drugs...
C4X Discovery Holdings plc has licenced its oral C4XD oral IL-17A inhibitor programme to Sanofi.
Share
